247 related articles for article (PubMed ID: 17671040)
1. Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy.
Beltrand J; Beregszaszi M; Chevenne D; Sebag G; De Kerdanet M; Huet F; Polak M; Tubiana-Rufi N; Lacombe D; De Paoli AM; Levy-Marchal C
Pediatrics; 2007 Aug; 120(2):e291-6. PubMed ID: 17671040
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience.
Araujo-Vilar D; Sánchez-Iglesias S; Guillín-Amarelle C; Castro A; Lage M; Pazos M; Rial JM; Blasco J; Guillén-Navarro E; Domingo-Jiménez R; del Campo MR; González-Méndez B; Casanueva FF
Endocrine; 2015 May; 49(1):139-47. PubMed ID: 25367549
[TBL] [Abstract][Full Text] [Related]
3. Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin.
Beltrand J; Lahlou N; Le Charpentier T; Sebag G; Leka S; Polak M; Tubiana-Rufi N; Lacombe D; de Kerdanet M; Huet F; Robert JJ; Chevenne D; Gressens P; Lévy-Marchal C
Eur J Endocrinol; 2010 Jun; 162(6):1083-91. PubMed ID: 20236991
[TBL] [Abstract][Full Text] [Related]
4. [Therapy resistant diabetes mellitus and lipodystrophy: leptin therapy leads to improvement].
Jazet IM; Jonker JT; Wijngaarden MA; Lamb H; Smelt AH
Ned Tijdschr Geneeskd; 2013; 157(4):A5482. PubMed ID: 23343738
[TBL] [Abstract][Full Text] [Related]
5. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
[TBL] [Abstract][Full Text] [Related]
6. [Difficult to manage diabetes mellitus associated with generalized congenital lipodystrophy. Report of two cases].
Cardona-Hernández R; Suárez-Ortega L; Torres M
An Pediatr (Barc); 2011 Feb; 74(2):126-30. PubMed ID: 21168376
[TBL] [Abstract][Full Text] [Related]
7. A case of Berardinelli-Seip syndrome presenting with cirrhosis.
Wimalaratna H; Nandasiri AS
J R Coll Physicians Edinb; 2013; 43(4):309-11. PubMed ID: 24350312
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular aspects of Berardinelli-Seip Congenital Lipodystrophy (BSCL).
Gomes KB; Pardini VC; Fernandes AP
Clin Chim Acta; 2009 Apr; 402(1-2):1-6. PubMed ID: 19167372
[TBL] [Abstract][Full Text] [Related]
9. Dental and periodontal alterations in Berardinelli-Seip syndrome.
Lima DL; Montenegro Júnior RM; Fernandes VO; Barros AI; Rêgo DM
J Int Acad Periodontol; 2007 Apr; 9(2):63-7. PubMed ID: 17506386
[TBL] [Abstract][Full Text] [Related]
10. Seipin ablation in mice results in severe generalized lipodystrophy.
Cui X; Wang Y; Tang Y; Liu Y; Zhao L; Deng J; Xu G; Peng X; Ju S; Liu G; Yang H
Hum Mol Genet; 2011 Aug; 20(15):3022-30. PubMed ID: 21551454
[TBL] [Abstract][Full Text] [Related]
11. Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy.
Boutet E; El Mourabit H; Prot M; Nemani M; Khallouf E; Colard O; Maurice M; Durand-Schneider AM; Chrétien Y; Grès S; Wolf C; Saulnier-Blache JS; Capeau J; Magré J
Biochimie; 2009 Jun; 91(6):796-803. PubMed ID: 19278620
[TBL] [Abstract][Full Text] [Related]
12. [Genetic and metabolic description of five patients with Berardinelli-Seip syndrome].
Barra CB; Savoldelli RD; Manna TD; Kim CA; Magre J; Porta G; Setian N; Damiani D
Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):54-9. PubMed ID: 21468520
[TBL] [Abstract][Full Text] [Related]
13. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency.
Antuna-Puente B; Boutet E; Vigouroux C; Lascols O; Slama L; Caron-Debarle M; Khallouf E; Lévy-Marchal C; Capeau J; Bastard JP; Magré J
J Clin Endocrinol Metab; 2010 Mar; 95(3):1463-8. PubMed ID: 20097706
[TBL] [Abstract][Full Text] [Related]
14. Berardinelli-Seip syndrome in peritoneal dialysis.
Bande-Fernández JJ; García-Castro R; Sánchez-Alvarez JE; Rodríguez-Suárez C; Coronel-Aguilar D; Hidalgo C; Istanbuli B; Merino-Bueno C; Del Rio-García L
Nefrologia; 2015; 35(5):493-6. PubMed ID: 26391816
[TBL] [Abstract][Full Text] [Related]
15. Across-species benefits of adrenalectomy on congenital generalized lipoatrophic diabetes: a review.
Contreras PH; Vigil P
Front Endocrinol (Lausanne); 2023; 14():1151873. PubMed ID: 38260129
[TBL] [Abstract][Full Text] [Related]
16. Retinopathy and Uveitis in Congenital Generalized Lipodystrophy with Hypertriglyceridemia and Uncontrolled Diabetes (Berardinelli-Seip Syndrome).
Rubaie KA; Raef H; Stone DU; Kozak I
Middle East Afr J Ophthalmol; 2019; 26(4):250-252. PubMed ID: 32153340
[TBL] [Abstract][Full Text] [Related]
17. Berardinelli-Seip Congenital Generalised Lipodystrophy.
Cheema HA; Malik HS; Waheed N; Mushtaq I; Fayyaz Z; Anjum MN
J Coll Physicians Surg Pak; 2018 May; 28(5):406-408. PubMed ID: 29690976
[TBL] [Abstract][Full Text] [Related]
18. Berardinelli-Seip congenital lipodystrophy.
Mandal K; Aneja S; Seth A; Khan A
Indian Pediatr; 2006 May; 43(5):440-5. PubMed ID: 16735770
[TBL] [Abstract][Full Text] [Related]
19. Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin.
Diker-Cohen T; Cochran E; Gorden P; Brown RJ
J Clin Endocrinol Metab; 2015 May; 100(5):1802-10. PubMed ID: 25734254
[TBL] [Abstract][Full Text] [Related]
20. Early course of Berardinelli-Seip congenital lipodystrophy (BSCL).
Eltermann T; Menendez-Castro C; Kienzle HP; Wössner R; Thomas W
Klin Padiatr; 2010 Sep; 222(5):308-9. PubMed ID: 20301053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
